Short answer
COLLEGIUM PHARMACEUTICAL, INC (COLL) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 2026 results for the quarter ended March 31, 2026, announced May 7, 2026.
COLLEGIUM PHARMACEUTICAL, INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results for the quarter ended March 31, 2026, announced May 7, 2026
- Detailed financial results and management commentary available in Exhibit 99.1; furnished, not filed
Item 7.01 · Regulation FD Disclosure
- Earnings presentation released May 7, 2026 under Regulation FD
- Exhibit 99.2 contains management’s earnings-related disclosures
- Presentation furnished, not filed, limiting its status in formal SEC filings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other COLLEGIUM PHARMACEUTICAL, INC 8-K filings
Get the next COLL 8-K as it lands
Follow COLL for push alerts, or ask the research agent what this filing means.